Moderna Scores A Win In RSV — But Its Shares Don't Reflect That

Moderna Scores A Win In RSV — But Its Shares Don't Reflect That

The Food and Drug Administration granted Moderna's experimental RSV vaccine an expedited review, but Moderna stock dipped Monday.